Moderate-to-severe atopic dermatitis
Clinical trials for Moderate-to-severe atopic dermatitis explained in plain language.
Never miss a new study
Get alerted when new Moderate-to-severe atopic dermatitis trials appear
Sign up with your email to follow new studies for Moderate-to-severe atopic dermatitis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a new injection calm severe eczema?
Disease control Not yet recruitingThis early-stage trial tests an experimental drug called HXN5003 in healthy volunteers and in people with moderate-to-severe atopic dermatitis, a common form of eczema. The study first gives a single dose to healthy participants to check safety, then gives multiple doses to eczem…
Matched conditions: MODERATE-TO-SEVERE ATOPIC DERMATITIS
Phase 1 • Sponsor: Helixon Biotechnology (Suzhou) Co., Ltd • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New injection shows promise for tough eczema in early trial
Disease control Not yet recruitingThis Phase 2 study tests a new biologic drug called AK139 in 168 adults with moderate-to-severe atopic dermatitis (eczema) that hasn't improved with creams. Participants will receive either AK139 or a placebo by injection. The study aims to see if AK139 can safely clear skin and …
Matched conditions: MODERATE-TO-SEVERE ATOPIC DERMATITIS
Phase 2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New eczema pill shows promise in early trial
Disease control Not yet recruitingThis Phase 2 trial tests an experimental drug called CMS-D001 in 160 adults with moderate to severe atopic dermatitis (eczema) that hasn't responded well to creams. Participants will take one of three doses of the drug or a placebo daily for several weeks. The main goal is to see…
Matched conditions: MODERATE-TO-SEVERE ATOPIC DERMATITIS
Phase 2 • Sponsor: Dermavon Holdings Limited • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New eczema pill aims to calm angry skin
Symptom relief Not yet recruitingThis study tests an experimental capsule called QLS12010 in 160 adults with moderate-to-severe atopic dermatitis (eczema). The goal is to see if it reduces skin redness, itching, and rash better than a placebo over 16 weeks. Participants must have had eczema for at least one year…
Matched conditions: MODERATE-TO-SEVERE ATOPIC DERMATITIS
Phase 2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC